News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Swiss Biopharma Lumavita AG Raises $5.53 Million in New Series A Funding



6/19/2009 8:44:02 AM

pehub.com -- Lumavita AG, a Swiss developer of anti-infectives for women’s health, has raised CHF 6 million ($5.53m) in new Series A funding. The round total is now CHF 24 million ($22m). HealthCap led the tranche, and was joined by return backer Endeavour Vision.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES